Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

14.19
+1.047.91%
Post-market: 14.190.00000.00%16:10 EST
Volume:319.12K
Turnover:4.48M
Market Cap:262.70M
PE:-1.62
High:14.45
Open:13.50
Low:13.19
Close:13.15
52wk High:20.72
52wk Low:3.39
Shares:18.51M
Float Shares:11.60M
Volume Ratio:0.62
T/O Rate:2.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7421
EPS(LYR):-20.9087
ROE:-174.79%
ROA:-37.18%
PB:2.87
PE(LYR):-0.68

Loading ...

Piper Sandler Keeps Their Buy Rating on Avalo Therapeutics (AVTX)

TIPRANKS
·
Feb 04

Avalo Therapeutics nimmt an Investorenkonferenzen teil

Reuters
·
Feb 04

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case

Benzinga_recent_news
·
Feb 03

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Benzinga_recent_news
·
Feb 03

Avalo Therapeutics Initiated at Buy by Guggenheim

Dow Jones
·
Feb 02

Avalo Therapeutics initiated with a Buy at Guggenheim

TIPRANKS
·
Feb 02

Avalo Therapeutics Files $750 Million Mixed Shelf

MT Newswires Live
·
Jan 09

BRIEF-Avalo Therapeutics Files For Mixed Shelf Of Up To $750 Million - SEC Filing

Reuters
·
Jan 09

Avalo Therapeutics files $750M mixed securities shelf

TIPRANKS
·
Jan 09

Avalo Therapeutics Inc Files for Mixed Shelf of up to $750 Mln - SEC Filing

THOMSON REUTERS
·
Jan 09

U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar

Reuters
·
Dec 18, 2025

Avalo Therapeutics Unveils Pipeline Progress Highlighting Lead IL-1β Antibody for Hidradenitis Suppurativa

Reuters
·
Dec 02, 2025

Will Avalo Therapeutics (NASDAQ:AVTX) Spend Its Cash Wisely?

Simply Wall St.
·
Nov 08, 2025

Avalo Q3 net loss misses estimates, LOTUS trial enrollment complete

Reuters
·
Nov 06, 2025

Avalo Therapeutics reports third quarter revenue of zero dollars

Reuters
·
Nov 06, 2025

Avalo Therapeutics: Cash & Short-Term Investments of About $112 Mln as of Sept 30, Expected to Provide Runway Into 2028

THOMSON REUTERS
·
Nov 06, 2025

Avalo Therapeutics Q3 Operating Expenses USD 19.198 Million

THOMSON REUTERS
·
Nov 06, 2025

Press Release: Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

Dow Jones
·
Nov 06, 2025

Avalo Therapeutics Inc expected to post a loss of $1.66 a share - Earnings Preview

Reuters
·
Nov 03, 2025

Avalo Therapeutics to Participate in Piper Sandler Annual Healthcare Conference

Reuters
·
Nov 03, 2025